نتایج جستجو برای: a9 everolimus stents drug

تعداد نتایج: 602739  

2017
Pravesh Kumar Bundhun Girish Janoo Chandra Mouli Yanamala Feng Huang

BACKGROUND Controversies have been observed among network meta-analyses comparing biodegradable polymer drug-eluting stents (BP-DES) with durable polymer drug-eluting stents (DP-DES). We aimed to compare the adverse cardiovascular events associated with BP-DES and durable polymer everolimus-eluting stents (DP-EES) using a large number of patients obtained from randomized controlled trials (RCTs...

Journal: :the journal of tehran university heart center 0
seyfollah abdi rajaei cardiovascular, medical and research center, iran university of medical sciences, tehran, iran. hoseinali basiri rajaei cardiovascular, medical and research center, iran university of medical sciences, tehran, iran. negar salehi rajaei cardiovascular, medical and research center, iran university of medical sciences, tehran, iran. hamidreza pouraliakbar rajaei cardiovascular, medical and research center, iran university of medical sciences, tehran, iran. anoushiravan vakili-zarch rajaei cardiovascular, medical and research center, iran university of medical sciences, tehran, iran.

the coarctation of the aorta (coa) is rare in adulthood. diagnosis is made by clinical suspicion and physical findings such as blood pressure difference between the upper and lower extremities, pulse delay in the femoral artery, and systolic murmur over the thoracic spine.the coa in adulthood and in patients with associated aneurysm is challenging and different complications even with proper tr...

Journal: :Circulation. Cardiovascular interventions 2016
Fernando Alfonso María José Pérez-Vizcayno Bruno García Del Blanco Arturo García-Touchard José-Ramón López-Mínguez Mónica Masotti Javier Zueco Rafael Melgares Vicente Mainar Raul Moreno Antonio Domínguez Juan Sanchís Armando Bethencourt José Moreu Angel Cequier Vicens Martí Imanol Otaegui Teresa Bastante Nieves Gonzalo Pilar Jiménez-Quevedo Alberto Cárdenas Cristina Fernández

BACKGROUND Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR) is more challenging than that of patients with bare-metal stent ISR. However, the results of everolimus-eluting stents (EES) in these distinct scenarios remain unsettled. METHODS AND RESULTS A pooled analysis of the RIBS IV (Restenosis Intra-Stent of Drug-Eluting Stents: Paclitaxel-Eluting Balloon vs Ever...

Journal: :the journal of tehran university heart center 0
mohammad ali ostovan nemazee hospital, shiraz university of medical sciences, shiraz, iran. reza mollazadeh nemazee hospital, shiraz university of medical sciences, shiraz, iran.

background: small side branches, albeit less important than their larger counterparts, have not yet received due attention in the literature. nor has there ever been a comparison between drug-eluting stents and bare metal stents apropos side branch occlusion . the aim of this study was to compare the patency of small (≥0.5 and ≤1.5 mm in diameter) side branches with respect to bare metal vs. dr...

Journal: :JACC. Cardiovascular interventions 2011
Scot Garg Patrick W Serruys Sigmund Silber Joanna Wykrzykowska Robert Jan van Geuns Gert Richardt Pawel E Buszman Henning Kelbæk Adrianus Johannes van Boven Sjoerd H Hofma Axel Linke Volker Klauss William Wijns Carlos Macaya Philippe Garot Carlo DiMario Ganesh Manoharan Ran Kornowski Thomas Ischinger Antonio Bartorelli Eric Van Remortel Jacintha Ronden Stephan Windecker

OBJECTIVES This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents. BACKGROUND The SXscore can identify patients treated with PCI who are at highest risk of adverse events. METHODS The SXscore was calculated prospectively in 2,033 of the 2,292 patie...

Journal: :International journal of cardiology 2015
Diego Arroyo Gregoire Gendre Sara Schukraft Zacharenia Kallinikou Olivier Müller Gérard Baeriswyl Jean-Christophe Stauffer Jean-Jacques Goy Mario Togni Stéphane Cook Serban Puricel

BACKGROUND Data from randomized controlled trials have shown that the ABSORB BVS is non-inferior to Cobalt Chromium everolimus-eluting stents at 2years. METHODS & RESULTS The EVERBIO II trial (Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting Bioresorbable Vascular Scaffold) is a single-center, assessor-blind, randomized controlled trial enrolling 240 pati...

Journal: :Circulation. Cardiovascular interventions 2017
Ahmed N Mahmoud Amr F Barakat Akram Y Elgendy Erik Schneibel Amgad Mentias Ahmed Abuzaid Islam Y Elgendy

BACKGROUND Data regarding the long-term efficacy and safety of everolimus-eluting bioresorbable vascular scaffolds (BVS) compared with everolimus-eluting stents are limited. This meta-analysis aimed to compare the long-term outcomes with both devices. METHODS AND RESULTS Randomized trials reporting clinical outcomes beyond 1 year and comparing BVS with everolimus-eluting stents were included....

2012
Fumiyuki Otsuka Masataka Nakano Elena Ladich Frank D. Kolodgie Renu Virmani

Several randomized and observational studies have reported steady increase in cumulative incidence of late and very late ST (LST/VLST) following first-generation drug-eluting stents (DES: sirolimus-(SES) and paclitaxel-(PES)) up to 5 years. Pathologic studies have identified uncovered struts as the primary substrate responsible for LST/VLST following DES, where delayed arterial healing is assoc...

Journal: :Journal of the American College of Cardiology 2013
Kenneth Tandjung Hanim Sen Ming Kai Lam Mounir W Z Basalus J Hans W Louwerenburg Martin G Stoel K Gert van Houwelingen Frits H A F de Man Gerard C M Linssen Salah A M Saïd Mark B Nienhuis Marije M Löwik Patrick M J Verhorst Job van der Palen Clemens von Birgelen

OBJECTIVES The aim of this study was to assess the safety and efficacy of the implantation of Resolute zotarolimus-eluting stents (ZES) (Medtronic Inc., Santa Rosa, California) and Xience V everolimus-eluting stents (EES) (Abbott Vascular, Santa Clara, California) following strict discontinuation of dual antiplatelet therapy (DAPT) after 12 months. BACKGROUND Only limited long-term follow-up ...

Journal: :Journal of the Society for Cardiovascular Angiography & Interventions 2023

PCI for long, diffuse lesions may often require multiple stents. Concerns remain with overlapping stents, including geographic miss involving two increase in procedural time, contrast use, radiation dose and cost. The availability use of longer stents can circumvent the need facilitate interventional management patients coronary artery lesions. prospective, single-arm, open-label SPIRIT 48 tria...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید